Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
- 1 September 1993
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (9) , 1346-1349
- https://doi.org/10.1161/01.atv.13.9.1346
Abstract
Lipoprotein(a) [Lp(a)] has been proposed as a restenosis risk factor, but it is not known if Lp(a) is present in the injured arterial wall during the initial neointimal growth. The purpose of this study was to determine if Lp(a) is incorporated into the vessel wall during rapid neointimal formation after arterial injury in primates. In this model, distention of the iliac artery with an angioplasty catheter caused focal breaks in the internal elastic lamina (IEL) in 80% of the vessels and extensive IEL fragmentation with medial disruption in 20% of the vessels. Neointimal growth was noted in all injured arteries; thrombus formation was noted in 40% of the vessels. Based on morphometric measurements, injured arteries had neointimal areas of 0.41±0.05 (n=4) and 0.83±0.23 (n=6) mm2 at 14 and 28 days after injury, respectively. Control arteries had an intact IEL and a monolayer of intimal cells. Lp(a) localization was examined histologically by using a mouse monoclonal anti-Lp(a) antibody. Lp(a), found in all injured arteries, was localized primarily in the neointima in 50% of the vessels. In the subset of vessels with evidence of thrombus formation, intense Lp(a) immunostaining was associated with the thrombus. Lp(a) was specific to injured arteries as uninjured vessels did not stain. In addition, staining was not seen with a negative control, a nonspecific mouse IgG1 antibody. The presence of Lp(a) at the site of rapid neointimal growth supports a role for this lipoprotein in the response to vascular injury after balloon angioplasty.Keywords
This publication has 16 references indexed in Scilit:
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic StrokeNew England Journal of Medicine, 1991
- Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole MoodEuropean Journal of Pharmacology, 1990
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- Inhibition of platelet function with indobufen: Correlation with plasma drug levelThrombosis Research, 1985
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabeticsThrombosis Research, 1982
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962